Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sulfonylurea Compounds | 2 | 2022 | 17 | 0.320 |
Why?
|
| Dengue Virus | 2 | 2018 | 96 | 0.250 |
Why?
|
| Antiviral Agents | 2 | 2018 | 195 | 0.230 |
Why?
|
| Curcumin | 2 | 2015 | 118 | 0.190 |
Why?
|
| Anti-HIV Agents | 2 | 2015 | 486 | 0.160 |
Why?
|
| Virus Replication | 3 | 2018 | 318 | 0.150 |
Why?
|
| Microglia | 1 | 2022 | 208 | 0.150 |
Why?
|
| Diarylheptanoids | 1 | 2018 | 2 | 0.150 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2018 | 12 | 0.150 |
Why?
|
| Inflammation | 1 | 2022 | 758 | 0.120 |
Why?
|
| Drug Design | 1 | 2017 | 186 | 0.120 |
Why?
|
| Antimalarials | 1 | 2016 | 64 | 0.120 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 458 | 0.120 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2015 | 57 | 0.110 |
Why?
|
| Drugs, Generic | 1 | 2014 | 6 | 0.110 |
Why?
|
| Drug Industry | 1 | 2014 | 18 | 0.110 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2014 | 229 | 0.100 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 386 | 0.100 |
Why?
|
| Antidepressive Agents | 1 | 2012 | 65 | 0.090 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2012 | 81 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2022 | 1124 | 0.080 |
Why?
|
| HIV-1 | 1 | 2015 | 755 | 0.080 |
Why?
|
| Hippocampus | 1 | 2012 | 594 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 1596 | 0.060 |
Why?
|
| Depression | 1 | 2012 | 863 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2022 | 1621 | 0.060 |
Why?
|
| Cell Line | 2 | 2018 | 1410 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2022 | 2157 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2022 | 506 | 0.040 |
Why?
|
| Animals | 4 | 2022 | 16992 | 0.040 |
Why?
|
| HIV Infections | 1 | 2014 | 2586 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2022 | 570 | 0.040 |
Why?
|
| Cricetinae | 1 | 2018 | 241 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2018 | 139 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2022 | 876 | 0.030 |
Why?
|
| Mice | 2 | 2022 | 6644 | 0.030 |
Why?
|
| Amodiaquine | 1 | 2016 | 2 | 0.030 |
Why?
|
| Quinacrine | 1 | 2016 | 5 | 0.030 |
Why?
|
| Replicon | 1 | 2016 | 7 | 0.030 |
Why?
|
| Mefloquine | 1 | 2016 | 4 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2015 | 52 | 0.030 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2015 | 35 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2016 | 108 | 0.030 |
Why?
|
| Half-Life | 1 | 2015 | 63 | 0.030 |
Why?
|
| Heme Oxygenase-1 | 1 | 2015 | 52 | 0.030 |
Why?
|
| Autophagy | 1 | 2016 | 140 | 0.030 |
Why?
|
| Humans | 5 | 2018 | 43102 | 0.030 |
Why?
|
| Drug Stability | 1 | 2015 | 129 | 0.030 |
Why?
|
| Technology Transfer | 1 | 2014 | 2 | 0.030 |
Why?
|
| Therapeutic Equivalency | 1 | 2014 | 4 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2015 | 113 | 0.030 |
Why?
|
| World Health Organization | 1 | 2014 | 36 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 532 | 0.030 |
Why?
|
| Quality Control | 1 | 2014 | 42 | 0.030 |
Why?
|
| International Cooperation | 1 | 2014 | 52 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2014 | 56 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 945 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 104 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 408 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 532 | 0.030 |
Why?
|
| Developing Countries | 1 | 2014 | 113 | 0.030 |
Why?
|
| Helplessness, Learned | 1 | 2012 | 2 | 0.020 |
Why?
|
| Rats, Inbred WKY | 1 | 2012 | 17 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2012 | 283 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 2676 | 0.020 |
Why?
|
| Motor Activity | 1 | 2012 | 437 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 3735 | 0.010 |
Why?
|
| Male | 1 | 2012 | 23409 | 0.010 |
Why?
|